Clinical Trials Browser

Phase 2 × NETWORK × treosulfan × Clear all

NCT01772953 2016-10-12

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

Phase 2 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute